|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006142,
umls-concept:C0014180,
umls-concept:C0017262,
umls-concept:C0030705,
umls-concept:C0035696,
umls-concept:C0037657,
umls-concept:C0039286,
umls-concept:C0185117,
umls-concept:C0232970,
umls-concept:C0242210,
umls-concept:C2911684
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
1996-6-20
|
|
pubmed:abstractText |
Insulin-like growth factor I (IGF-I) is known to mediate estrogen effect in the uterus, whereas IGF binding proteins (IGFBPs) modulate the biologic effects of IGF-I. Tamoxifen may act via the IGF-IGFBP system in the postmenopausal endometrium.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
76
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1406-10
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:8620415-Aged,
pubmed-meshheading:8620415-Antineoplastic Agents, Hormonal,
pubmed-meshheading:8620415-Blotting, Northern,
pubmed-meshheading:8620415-Breast Neoplasms,
pubmed-meshheading:8620415-Cross-Sectional Studies,
pubmed-meshheading:8620415-Endometrium,
pubmed-meshheading:8620415-Estrogen Antagonists,
pubmed-meshheading:8620415-Female,
pubmed-meshheading:8620415-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:8620415-Humans,
pubmed-meshheading:8620415-Insulin-Like Growth Factor Binding Proteins,
pubmed-meshheading:8620415-Insulin-Like Growth Factor I,
pubmed-meshheading:8620415-Insulin-Like Growth Factor II,
pubmed-meshheading:8620415-Middle Aged,
pubmed-meshheading:8620415-Postmenopause,
pubmed-meshheading:8620415-RNA, Messenger,
pubmed-meshheading:8620415-Somatomedins,
pubmed-meshheading:8620415-Tamoxifen
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
The expression of insulin-like growth factor and its binding protein mRNA in the endometrium of postmenopausal patients with breast cancer receiving tamoxifen.
|
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, University of Oulu, Finland.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
